Cited by 2,287Pregnancy and preeclampsia studiesNeurological Complications and SyndromesNeonatal and fetal brain pathology

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia

Open access

Rolnik, Daniel L., Wright, David, Poon, Liona C., O’Gorman, Neil, Syngelaki, Argyro, de Paco Matallana, Catalina, Akolekar, Ranjit, Cicero, Simona, Janga, Deepa, Singh, Mandeep, Molina, Francisca S., Persico, Nicola, Jani, Jacques C., Plasencia, Walter, Papaioannou, George, Tenenbaum-Gavish, Kinneret, Meiri, Hamutal, Gizurarson, Sveinbjorn, Maclagan, Kate, Nicolaides, Kypros H.·2017·New England Journal of Medicine

DOI 10.1056/nejmoa1704559

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Preterm preeclampsia is an important cause of maternal and perinatal death and complications. It is uncertain whether the intake of low-dose aspirin during pregnancy reduces the risk of preterm preeclampsia. METHODS: In this multicenter, double-blind, placebo-controlled trial, we randomly assigned 1776 women with singleton pregnancies who were at high risk for preterm preeclampsia to receive aspirin, at a dose of 150 mg per day, or placebo from 11 to 14 weeks of gestation until 36 weeks of gestation. The primary outcome was delivery with preeclampsia before 37 weeks of gestation. The analysis was performed according to the intention-to-treat principle. RESULTS: A total of 152 women withdrew consent during the trial, and 4 were lost to follow up, which left 798 participants in the aspirin group and 822 in the placebo group. Preterm preeclampsia occurred in 13 participants (1.6%) in the aspirin group, as compared with 35 (4.3%) in the placebo group (odds ratio in the aspirin group, 0.38; 95% confidence interval, 0.20 to 0.74; P=0.004). Results were materially unchanged in a sensitivity analysis that took into account participants who had withdrawn or were lost to follow-up. Adherence was good, with a reported intake of 85% or more of the required number of tablets in 79.9% of the participants. There were no significant between-group differences in the incidence of neonatal adverse outcomes or other adverse events. CONCLUSIONS: Treatment with low-dose aspirin in women at high risk for preterm preeclampsia resulted in a lower incidence of this diagnosis than placebo. (Funded by the European Union Seventh Framework Program and the Fetal Medicine Foundation; EudraCT number, 2013-003778-29 ; Current Controlled Trials number, ISRCTN13633058 .).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1704559

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Untitled work
(2013) · doi:10.1097/01.aog.0000437382.03963.88 · Cited by 3,961
The Global Impact of Pre-eclampsia and Eclampsia
Duley, L. (2009) · Seminars in Perinatology · doi:10.1053/j.semperi.2009.02.010 · Cited by 2,866
THE CLASSIFICATION AND DIAGNOSIS OF THE HYPERTENSIVE DISORDERS OF PREGNANCY: STATEMENT FROM THE INTERNATIONAL SOCIETY FOR THE STUDY OF HYPERTENSION IN PREGNANCY (ISSHP)
Brown, M. A., Lindheimer, M. D., de Swiet, M., Assche, A. V., & Moutquin, J. (2001) · Hypertension in Pregnancy · doi:10.1081/prg-100104165 · Cited by 1,894
A CRITICAL EVALUATION OF SONAR “CROWN‐RUMP LENGTH” MEASUREMENTS
Robinson, H. P., & Fleming, J. E. E. (1975) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1975.tb00710.x · Cited by 1,413
The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)
Brown, M. A., Lindheimer, M. D., de SWIET, M., et al. (2001) · Hypertension in Pregnancy · doi:10.3109/10641950109152635 · Cited by 1,369
Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy
Bujold, E., Roberge, S., Lacasse, Y., Bureau, M., Audibert, F., Marcoux, S., Forest, J., & Giguère, Y. (2010) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181e9322a · Cited by 1,112
Long term mortality of mothers and fathers after pre-eclampsia: population based cohort studyPre-eclampsia and cardiovascular disease later in life: who is at risk?
Irgens, H. U., Roberts, J. M., Reisæter, L., Irgens, L. M., & Lie, R. T. (2001) · BMJ · doi:10.1136/bmj.323.7323.1213 · Cited by 1,040
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data
Askie, L. M., Duley, L., Henderson-Smart, D. J., & Stewart, L. A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60712-0 · Cited by 1,025
Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease
Lisonkova, S., & Joseph, K. S. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.08.019 · Cited by 926
The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis
Roberge, S., Nicolaides, K., Demers, S., Hyett, J., Chaillet, N., & Bujold, E. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.09.076 · Cited by 679
Self-citation

Flagged first, then by citations

Show all 24 references

Research works printed but not linked: 2

National Collaborating Centre for Women’s and Children’s Health (UK). Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. London: RCOG Press, 2010.
Van Buuren S, 2011, J Stat Softw, 45, 1

Sorted by citations

Items 201–300 of 1,002

Outcome of cesarean scar pregnancy according to gestational age at diagnosis: A systematic review and meta-analysis
Timor‐Tritsch, I. E., Buca, D. I. P., Mascio, D. D., Calì, G., D’Amico, A., Monteagudo, A., Tinari, S., Morlando, M., Nappi, L., Greco, P., et al. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.11.036 · Cited by 73
Pre‐eclampsia and the cardiovascular–placental axis
Thilaganathan, B. (2018) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.19081 · Cited by 72
Posicionamento da Sociedade Brasileira de Cardiologia para Gravidez e Planejamento Familiar na Mulher Portadora de Cardiopatia – 2020
Ávila, W. S., Alexandre, E. R. G., de Castro, M. L., de Lucena, A. J. G., Marques-Santos, C., Freire, C. M. V., Rossi, E. G., Campanharo, F. F., Rivera, I. R., Costa, M. E. N. C., et al. (2020) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20200406 · Cited by 77
Clinical implementation of the sFlt-1/PlGF ratio to identify preeclampsia and fetal growth restriction: A prospective cohort study
Herraı̀z, I., Simon, E. D. S., Gómez‐Arriaga, P. I., Quezada, M. S., García-Burguillo, A., López-Jiménez, E. A., & Galindo, A. (2018) · Pregnancy Hypertension · doi:10.1016/j.preghy.2018.06.017 · Cited by 72
Thrombocytopenia in pregnancy: Diagnosis and approach to management
Pishko, A. M., Levine, L. D., & Cines, D. B. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.100638 · Cited by 70
Does low-dose aspirin initiated before 11 weeks’ gestation reduce the rate of preeclampsia?
Chaemsaithong, P., Cuenca-Gómez, D., Plana, N., Gil, M. M., & Poon, L. C. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.08.047 · Cited by 73
Self-citation
Beta-Arrestin1 Prevents Preeclampsia by Downregulation of Mechanosensitive AT1-B2 Receptor Heteromers
Quitterer, U., Fu, X., Pohl, A., Bayoumy, K. M., Langer, A., & AbdAlla, S. (2018) · Cell · doi:10.1016/j.cell.2018.10.050 · Cited by 69
Magnetic resonance imaging for prenatal estimation of birthweight in pregnancy: review of available data, techniques, and future perspectives
Kadji, C., Cannie, M., Resta, S., Guez, D., Abi-Khalil, F., Angelis, R. D., & Jani, J. C. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.12.031 · Cited by 68
Self-citation
Preeclampsia: a defect in decidualization is associated with deficiency of Annexin A2
Garrido‐Gómez, T., Quiñonero, A., Domı́nguez, F., Rubert, L., Alfredo Perales, M., Hajjar, K. A., & Simón, C. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.11.1250 · Cited by 68
Prediction of imminent preeclampsia at 35–37 weeks gestation
Ciobanu, A. M., Wright, A., Panaitescu, A. M., Syngelaki, A., Wright, D. E., & Nicolaides, K. H. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.01.235 · Cited by 68
Self-citation
A Systematic Review of Vascular Structure and Function in Pre-eclampsia: Non-invasive Assessment and Mechanistic Links
Kirollos, S., Skilton, M. R., Patel, S., & Arnott, C. G. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00166 · Cited by 67
The great obstetrical syndromes and the placenta
Hoffman, M. (2023) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17613 · Cited by 72
Chronic hypertension: first-trimester blood pressure control and likelihood of severe hypertension, preeclampsia, and small for gestational age
Nzelu, D., Dumitrascu‐Biris, D., Nicolaides, K. H., & Kametas, N. A. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.12.235 · Cited by 72
Self-citation
Predictive value of sFlt-1, PlGF, sFlt-1/PlGF ratio and PAPP-A for late-onset preeclampsia and IUGR between 32 and 37 weeks of pregnancy
Birdir, C., Droste, L., Fox, L., Frank, M., Fryze, J., Enekwe, A., Köninger, A., Kimmig, R., Schmidt, B., & Gellhaus, A. (2018) · Pregnancy Hypertension · doi:10.1016/j.preghy.2018.04.010 · Cited by 67
Hydroxychloroquine may be beneficial in preeclampsia and recurrent miscarriage
MOREUIL, C. D., Alavi, Z., & Pasquier, É. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14131 · Cited by 67
The assessment of blood pressure in pregnant women: pitfalls and novel approaches
Hurrell, A., Webster, L., Chappell, L. C., & Shennan, A. H. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.10.026 · Cited by 66
Preeclampsia and the cardiovascular system: An update
Perry, H., Khalil, A. A., & Thilaganathan, B. (2018) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.04.009 · Cited by 66
Routine ultrasound at 32 vs 36 weeks' gestation: prediction of small‐for‐gestational‐age neonates
Ciobanu, A.-M., Khan, N., Syngelaki, A., Akolekar, R., & Nicolaides, K. H. (2019) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.20258 · Cited by 66
Self-citation
Neurology of Preeclampsia and Related Disorders: an Update in Neuro-obstetrics
Miller, E. C., & Vollbracht, S. (2021) · Current Pain and Headache Reports · doi:10.1007/s11916-021-00958-z · Cited by 65
Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunction
McLaughlin, K., Hobson, S. R., Chandran, A. R., Agrawal, S., Windrim, R. C., Parks, W. T., BOWMAN, A. W., Sovio, U., Smith, G. C. S., & Kingdom, J. C. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.08.027 · Cited by 65
Antiphospholipid syndrome management: a 2023 update and practical algorithm-based approach
Ambati, A., Knight, J. S., & Zuo, Y. (2023) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000932 · Cited by 68
Preeclampsia up to date—What’s going on?
Bokuda, K., & Ichihara, A. (2023) · Hypertension Research · doi:10.1038/s41440-023-01323-w · Cited by 65
Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets
Benhalima, K., Beunen, K., Siegelaar, S. E., Painter, R. C., Murphy, H. R., Feig, D. S., Donovan, L., Polsky, S., Buschur, E., Levy, C. J., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00116-x · Cited by 66
Comparison of three commercially available placental growth factor‐based tests in women with suspected preterm pre‐eclampsia: the COMPARE study
McCarthy, F. P., Gill, C. A., Seed, P. T., Bramham, K., Chappell, L. C., & Shennan, A. H. (2018) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.19051 · Cited by 65
Gestational Hypertension and Preeclampsia: An Overview of National and International Guidelines
Tsakiridis, I., Giouleka, S., Arvanitaki, A., Giannakoulas, G., Papazisis, G., Mamopoulos, A., Athanasiadis, A., & Dagklis, T. (2021) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000942 · Cited by 64
First trimester biomarkers for prediction of gestational diabetes mellitus
Tenenbaum-Gavish, K., Sharabi‐Nov, A., Binyamin, D., Møller, H. J., Danon, D., Rothman, L., Hadar, E., Idelson, A., Vogel, I., Koren, O., et al. (2020) · Placenta · doi:10.1016/j.placenta.2020.08.020 · Cited by 64
Self-citation
Accuracy of placental growth factor alone or in combination with soluble fms-like tyrosine kinase-1 or maternal factors in detecting preeclampsia in asymptomatic women in the second and third trimesters: a systematic review and meta-analysis
Chaemsaithong, P., Gil, M. M., Chaiyasit, N., Cuenca-Gómez, D., Plasencia, W., Rollé, V., & Poon, L. C. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2023.03.032 · Cited by 65
Self-citation
Home blood‐pressure monitoring in a hypertensive pregnant population: cost‐minimization study
Xydopoulos, G., Perry, H., Sheehan, E., Thilaganathan, B., Fordham, R. J., & Khalil, A. A. (2018) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.19041 · Cited by 64
Cost‐effectiveness of first‐trimester screening with early preventative use of aspirin in women at high risk of early‐onset pre‐eclampsia
Ortved, D., Hawkins, T. L., Johnson, J.-A., Hyett, J. A., & Metcalfe, A. (2018) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.19076 · Cited by 65
Platelet function in preeclampsia – a systematic review and meta-analysis
Jakobsen, C., Larsen, J. B., Fuglsang, J., & Hvas, A. (2019) · Platelets · doi:10.1080/09537104.2019.1595561 · Cited by 63
Exploiting the placenta for nanoparticle-mediated drug delivery during pregnancy
Figueroa‐Espada, C. G., Hofbauer, S. I., Mitchell, M. J., & Riley, R. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.09.006 · Cited by 65
Development of a prediction model on preeclampsia using machine learning-based method: a retrospective cohort study in China
Liu, M., Yang, X., Chen, G., Ding, Y., Shi, M., Sun, L., Huang, Z., Liu, J., Liu, T., Yan, R., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.896969 · Cited by 65
Perspectives on the Use of Placental Growth Factor (PlGF) in the Prediction and Diagnosis of Pre-Eclampsia: Recent Insights and Future Steps
Creswell, L., O’Gorman, N., Palmer, K. R., Costa, F. D. S., & Rolnik, D. L. (2023) · International Journal of Women s Health · doi:10.2147/ijwh.s368454 · Cited by 68
Self-citation
Comparing aspirin 75 to 81 mg vs 150 to 162 mg for prevention of preterm preeclampsia: systematic review and meta-analysis
Ghesquière, L., Guerby, P., Marchant, I., Kumar, N., Zare, M., Foisy, M.-A., Roberge, S., & Bujold, E. (2023) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2023.101000 · Cited by 64
Management of hypertensive disorders in pregnancy: a Position Statement of the European Society of Hypertension Working Group ‘Hypertension in Women’
Thomopoulos, C., Hitij, J. B., Backer, T. L. M. D., Gkaliagkousi, Ε., Kreutz, R. H., Lopez‐Sublet, M., Marketou, M. E., Mihailidou, A. S., Olszanecka, A., Péchère-Bertschi, A., et al. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003739 · Cited by 64
The role of interleukins in preeclampsia: A comprehensive review
Bellos, I., Karageorgiou, V., Kapnias, D., Karamanli, K., & Siristatidis, C. S. (2018) · American Journal of Reproductive Immunology · doi:10.1111/aji.13055 · Cited by 64
Two-stage screening for preterm preeclampsia at 11–13 weeks’ gestation
Wright, A., Wright, D. E., Syngelaki, A., Georgantis, A., & Nicolaides, K. H. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.10.092 · Cited by 63
Self-citation
The Road to Low-Dose Aspirin Therapy for the Prevention of Preeclampsia Began with the Placenta
Walsh, S. W., & Strauss, J. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136985 · Cited by 64
Machine‐learning‐based prediction of pre‐eclampsia using first‐trimester maternal characteristics and biomarkers
Ansbacher‐Feldman, Z., Syngelaki, A., Meiri, H., Cirkin, R., Nicolaides, K. H., & Louzoun, Y. (2022) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.26105 · Cited by 62
Self-citation
Aspirin Discontinuation at 24 to 28 Weeks’ Gestation in Pregnancies at High Risk of Preterm Preeclampsia
Mendoza, M., Bonacina, E., García‐Manau, P., López, M., Caamiña, S., Vives, À., López‐Quesada, E., Ricart, M., Maroto, A., de Mingo, L., et al. (2023) · JAMA · doi:10.1001/jama.2023.0691 · Cited by 62
Preeclampsia: Insights into pathophysiological mechanisms and preventive strategies
Martini, C., Saeed, Z., Simeone, P., Palma, S., Ricci, M., Arata, A., Sorella, A., Liani, R., Ricci, F., D’Antonio, F., et al. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.101054 · Cited by 62
Novel Interventions for the Prevention of Preeclampsia
Ma’ayeh, M., Rood, K. M., Kniss, D. A., & Costantine, M. M. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-1026-8 · Cited by 64
Competing‐risks model for prediction of small‐for‐gestational‐age neonate from biophysical and biochemical markers at 11–13 weeks' gestation
Papastefanou, I., Wright, D., Syngelaki, A., Souretis, K., Chrysanthopoulou, E. L., & Nicolaides, K. H. (2020) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.23523 · Cited by 63
Self-citation
Serum PlGF compared with PAPP‐A in first trimester screening for preterm pre‐eclampsia: Adjusting for the effect of aspirin treatment
Wright, D. E., Tan, M. Y., O’Gorman, N., Syngelaki, A., & Nicolaides, K. H. (2022) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17096 · Cited by 60
Self-citation
Relationship between vitamin D status in pregnancy and the risk for preeclampsia: A nested case-control study
Benachi, A., Baptiste, A., Taieb, J., Tsatsaris, V., Guibourdenche, J., Sénat, M., Haidar, H., Jani, J. C., Guizani, M., Jouannic, J., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.02.015 · Cited by 60
Self-citation
Peripartum management of hypertension: a position paper of the ESC Council on Hypertension and the European Society of Hypertension
Cífková, R., Johnson, M. R., Kahan, T., Brguljan-Hitij, J., Williams, B., Coca, A., Manolis, A. J., Thomopoulos, C., Borghi, C., Tsioufis, C. P., et al. (2019) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvz082 · Cited by 63
Impact of new definitions of pre‐eclampsia on incidence and performance of first‐trimester screening
Khan, N., Andrade, W., De Castro, H., Wright, A., Wright, D., & Nicolaides, K. H. (2020) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.21867 · Cited by 59
Self-citation
Cardiovascular Sequels During and After Preeclampsia
Paauw, N. D., & Lely, A. T. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-77932-4_28 · Cited by 61
Evaluation of low-dose aspirin in the prevention of recurrent spontaneous preterm labour (the APRIL study): A multicentre, randomised, double-blinded, placebo-controlled trial
Landman, A. J. E. M. C., de Boer, M. A., Visser, L., Nijman, T. A. J., Hemels, M. A. C., Naaktgeboren, C. A., der Weide, M. C. J., Mol, B. W., van Laar, J. O. E. H., Papatsonis, D. N. M., et al. (2022) · PLoS Medicine · doi:10.1371/journal.pmed.1003892 · Cited by 59
Aspirin reduces long-term stroke risk in women with prior hypertensive disorders of pregnancy
Miller, E. C., Boehme, A. K., Chung, N. T., Wang, S., Lacey, J. V., Lakshminarayan, K., Zhong, C., Woo, D., Bello, N. A., Wapner, R. J., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000006815 · Cited by 59
Pregnancy in Women with Cardiovascular Diseases
Adam, K. (2017) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-13-4-209 · Cited by 59
Diagnostic utility of serial circulating placental growth factor levels and uterine artery Doppler waveforms in diagnosing underlying placental diseases in pregnancies at high risk of placental dysfunction
Agrawal, S., Parks, W. T., Zeng, H. D., Ravichandran, A., Ashwal‏, E., Windrim, R. C., Hobson, S. R., Melamed, N., & Kingdom, J. C. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.05.043 · Cited by 57
National and international guidelines on the management of twin pregnancies: a comparative review
Weitzner, O., Barrett, J. F. R., Murphy, K. E., Kingdom, J. C., Aviram, A., Mei‐Dan, E., Hiersch, L., Ryan, G., Mieghem, T. V., Abbasi, N., et al. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2023.05.022 · Cited by 57
Trophoblast retrieval and isolation from the cervix: origins of cervical trophoblasts and their potential value for risk assessment of ongoing pregnancies
Moser, G., Drewlo, S., Huppertz, B., & Armant, D. R. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmy008 · Cited by 56
Management of pregnancies after combined screening for pre‐eclampsia at 19–24 weeks' gestation
Litwińska, M., Syngelaki, A., Wright, A., Wright, D. E., & Nicolaides, K. H. (2018) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.19099 · Cited by 56
Self-citation
Associations Between Migraine and Adverse Pregnancy Outcomes: Systematic Review and Meta-analysis
Aukes, A. M., Yurtsever, F. N., Boutin, A., de Visser, M. C. H., & de Groot, C. J. M. (2019) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000738 · Cited by 56
Pregnancy and autoimmune disease: diseases of the nervous system, connective tissue, and the bowel
Merz, W. M., Fischer‐Betz, R., Hellwig, K., Lamprecht, G., & Gembruch, U. (2022) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2021.0353 · Cited by 55
Hypertensive Disorders in Pregnancy: Global Burden From 1990 to 2019, Current Research Hotspots and Emerging Trends
Fu, R., Li, Y., Li, X., & Jiang, W. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.101982 · Cited by 56
Preventing maternal morbidity and mortality from preeclampsia and eclampsia particularly in low- and middle-income countries
Ngene, N. C., & Moodley, J. (2024) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2024.102473 · Cited by 55
Early Detection of Preeclampsia Using Circulating Small non-coding RNA
Yoffe, L., Gilam, A., Yaron, O., Polsky, A. L., Farberov, L., Syngelaki, A., Nicolaides, K. H., Hod, M., & Shomron, N. (2018) · Scientific Reports · doi:10.1038/s41598-018-21604-6 · Cited by 56
Self-citation
Population-based trends and risk factors of early- and late-onset preeclampsia in Taiwan 2001–2014
You, S.-H., Cheng, P., Chung, T., Kuo, C., Wu, H., & Chu, P. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-1845-7 · Cited by 61
Clinical risk assessment in early pregnancy for preeclampsia in nulliparous women: A population based cohort study
Sandström, A., Snowden, J. M., Höijer, J., Bottai, M., & Wikström, A.-K. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225716 · Cited by 58
Aspirin Prophylaxis During Pregnancy: A Systematic Review and Meta-Analysis
Choi, Y. J., & Shin, S. (2021) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2021.01.032 · Cited by 58
Adverse pregnancy outcomes in women with diabetes-related microvascular disease and risks of disease progression in pregnancy: A systematic review and meta-analysis
Relph, S., Patel, T., Delaney, L., Sobhy, S., & Thangaratinam, S. (2021) · PLOS Medicine · doi:10.1371/journal.pmed.1003856 · Cited by 54
Novel electronic health records applied for prediction of pre-eclampsia: Machine-learning algorithms
Li, Y., Shen, X., Yang, C., Cao, Z.-Z., Du, R., Yu, M.-D., Wang, J., & Wang, M. (2021) · Pregnancy Hypertension · doi:10.1016/j.preghy.2021.10.006 · Cited by 61
Research Recommendations From the National Institutes of Health Workshop on Predicting, Preventing, and Treating Preeclampsia
Maric‐Bilkan, C., Abrahams, V. M., Arteaga, S. S., Bourjeily, G. R., Conrad, K. P., Catov, J. M., Costantine, M. M., Cox, B., Garovic, V. D., George, E. M., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.11644 · Cited by 57
Novel approaches to combat preeclampsia: from new drugs to innovative delivery
de Alwis, N., Binder, N. K., Beard, S., Kaitu’u‐Lino, T. J., Tong, S., Brownfoot, F., & Hannan, N. J. (2020) · Placenta · doi:10.1016/j.placenta.2020.08.022 · Cited by 53
Validation of machine‐learning model for first‐trimester prediction of pre‐eclampsia using cohort from PREVAL study
Gil, M. M., Cuenca-Gómez, D., Rollé, V., Pertegal, M., Díaz, C., Revello, R., Adiego, B., Mendoza, M., Molina, F. S., Santacruz, B., et al. (2023) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.27478 · Cited by 53
Self-citation
Current insights in obstetric antiphospholipid syndrome
Schreiber, K. I., Radin, M., & Sciascia, S. (2017) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000406 · Cited by 53
Impact of the ACOG guideline regarding low-dose aspirin for prevention of superimposed preeclampsia in women with chronic hypertension
Banala, C., Moreno, S. C., Cruz, Y., Boelig, R. C., Saccone, G., Berghella, V., Schoen, C. N., & Roman, A. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.03.004 · Cited by 53
Risk of preterm birth in relation to history of preterm birth: a population‐based registry study of 213 335 women in Norway
Tingleff, T., Vikanes, Å. V., Räisänen, S., Sandvik, L., Murzakanova, G., & Laine, K. (2021) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17013 · Cited by 52
Low-dose aspirin for the prevention of superimposed preeclampsia in women with chronic hypertension: a systematic review and meta-analysis
Richards, E., Giorgione, V., Stevens, O., & Thilaganathan, B. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.09.046 · Cited by 53
Updates on the management of inflammatory bowel disease from periconception to pregnancy and lactation
Nielsen, O. H., Gubatan, J. M. B., Kolho, K., Streett, S. E., & Maxwell, C. V. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00052-7 · Cited by 52
Elevated vasopressin in pregnant mice induces T-helper subset alterations consistent with human preeclampsia
Scroggins, S. M., Santillan, D. A., Lund, J. M., Sandgren, J. A., Krotz, L., Hamilton, W. S., Devor, E. J., Davis, H., Pierce, G. L., Gibson-Corley, K. N., et al. (2018) · Clinical Science · doi:10.1042/cs20171059 · Cited by 53
Preeclampsia Prevention Using Routine Versus Screening Test–Indicated Aspirin in Low-Risk Women
Mone, F., O’Mahony, J. F., Tyrrell, E., Mulcahy, C., McParland, P., Breathnach, F., Morrison, J. J., Higgins, J., Daly, S., Cotter, A. M., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11718 · Cited by 52
Angiogenic Marker Prognostic Models in Pregnant Women With Hypertension
Perry, H., Binder, J., Kalafat, E., Jones, S., Thilaganathan, B., & Khalil, A. A. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.13997 · Cited by 52
Atractylenolide inhibits apoptosis and oxidative stress of HTR-8/SVneo cells by activating MAPK/ERK signalling in preeclampsia
Liu, M., Wang, R.-B., Xing, J.-H., & Tang, Y.-X. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153773 · Cited by 51
First-trimester mean arterial blood pressure and the risk of preeclampsia: The Great Obstetrical Syndromes (GOS) study
Gasse, C., Boutin, A., Côté, M. C., Chaillet, N., Bujold, E., & Demers, S. (2017) · Pregnancy Hypertension · doi:10.1016/j.preghy.2017.11.005 · Cited by 51
Prediction of pre‐eclampsia in twin pregnancy by maternal factors and biomarkers at 11–13 weeks' gestation: data from EVENTS trial
Benkő, Z., Wright, A., Rehal, A., Cimpoca-Raptis, B. A., Syngelaki, A., Delgado⋈, J. L., Tsokaki, T., de Alvarado, M., Vojtassakova, D., Ntalianis, K. M., et al. (2020) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.23531 · Cited by 51
Self-citation
Aspirin for the prevention of preeclampsia: A systematic review and meta-analysis of randomized controlled studies
Wang, Y., Guo, X., Obore, N., Ding, H., Wu, C., & Yu, H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.936560 · Cited by 50
New advances in prediction and surveillance of preeclampsia: role of machine learning approaches and remote monitoring
Hackelöer, M., Schmidt, L., & Verlohren, S. (2022) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-022-06864-y · Cited by 50
Should Maternal Hemodynamics Guide Antihypertensive Therapy in Preeclampsia?
McLaughlin, K., Scholten, R. R., Kingdom, J. C., Floras, J. S., & Parker, J. D. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10606 · Cited by 50
Preeclampsia Among African American Pregnant Women: An Update on Prevalence, Complications, Etiology, and Biomarkers
Zhang, M., Wan, P., Ng, K., Singh, K., Cheng, T. H., Velickovic, I. A., Dalloul, M., & Wlody, D. (2020) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000747 · Cited by 50
The Association of Adverse Pregnancy Outcomes and Cardiovascular Disease: Current Knowledge and Future Directions
Minhas, A., Ying, W., Ogunwole, S. M., Miller, M. J., Zakaria, S., Vaught, A. “. J., Hays, A. G., Creanga, A. A., Cedars, A. M., Michos, E. D., et al. (2020) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-020-00862-6 · Cited by 50
First Trimester Mean Platelet Volume, Neutrophil to Lymphocyte Ratio, and Platelet to Lymphocyte Ratio Values Are Useful Markers for Predicting Preeclampsia
Oğlak, S. C., Tunç, Ş., & Ölmez, F. (2021) · Ochsner Journal · doi:10.31486/toj.21.0026 · Cited by 50
Aspirin enhances trophoblast invasion and represses soluble fms-like tyrosine kinase 1 production
Su, M., Wang, C., Tsai, P., Chen, T.-Y., Tsai, H.-L., & Kuo, P. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002185 · Cited by 49
First‐trimester risk assessment based on ultrasound and cell‐free DNA vs combined screening: a randomized controlled trial
Kagan, K. O., Sroka, F., Sonek, J., Abele, H., Lüthgens, K., Schmid, M., Wagner, P., Brucker, S. Y., Wallwiener, D. R., & Hoopmann, M. (2017) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.18905 · Cited by 49
Everything the clinician needs to know about evidence-based anticoagulation in pregnancy
Scheres, L. J. J., Bistervels, I. M., & Middeldorp, S. (2018) · Blood Reviews · doi:10.1016/j.blre.2018.08.001 · Cited by 51
Adolescent Preeclampsia: Pathological Drivers and Clinical Prevention
Brosens, I. A., Muter, J., Ewington, L. J., Puttemans, P., Petraglia, F., Brosens, J. J., & Benagiano, G. (2018) · Reproductive Sciences · doi:10.1177/1933719118804412 · Cited by 49
Molecular Targets of Aspirin and Prevention of Preeclampsia and Their Potential Association with Circulating Extracellular Vesicles during Pregnancy
Dutta, S., Kumar, S., Hyett, J. A., & Salomón, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184370 · Cited by 51
First‐trimester pre‐eclampsia biomarker profiles in Asian population: multicenter cohort study
Chaemsaithong, P., Sahota, D. S., Pooh, R. K., Zheng, M., Ma, R., Chaiyasit, N., Koide, K., Shaw, S. W., Seshadri, S., Choolani, M. A., et al. (2019) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.21905 · Cited by 49
Self-citation
How we manage Philadelphia‐negative myeloproliferative neoplasms in pregnancy
Robinson, S. E., & Harrison, C. N. (2020) · British Journal of Haematology · doi:10.1111/bjh.16453 · Cited by 49
Hypertensive Disorders of Pregnancy and Fetal Growth Restriction: Clinical Characteristics and Placental Lesions and Possible Preventive Nutritional Targets
Martino, D. D. D., Avagliano, L., Ferrazzi, E. M., Fusè, F., Sterpi, V., Parasiliti, M., Stampalija, T., Zullino, S., Farina, A., Bulfamante, G., et al. (2022) · Nutrients · doi:10.3390/nu14163276 · Cited by 50
Stillbirth: prevention and supportive bereavement care
Atkins, B., Kindinger, L. M., Mahindra, M. P., Moatti, Z., & Siassakos, D. M. (2023) · BMJ Medicine · doi:10.1136/bmjmed-2022-000262 · Cited by 51
Early first‐trimester transvaginal ultrasound is indicated in pregnancy after previous Cesarean delivery: should it be mandatory?
Timor‐Tritsch, I. E., D'Antonio, F., Calì, G., Palacios-Jaraquemada, J. M., Meyer, J., & Monteagudo, A. (2019) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.20225 · Cited by 48
The association between first trimester AFP to PAPP-A ratio and placentally-related adverse pregnancy outcome
Hughes, A. E., Sovio, U., Gaccioli, F., Cook, E., Jones, D. S., & Smith, G. C. S. (2019) · Placenta · doi:10.1016/j.placenta.2019.04.005 · Cited by 48
Regulatory T Cells in Pregnancy Adverse Outcomes: A Systematic Review and Meta-Analysis
Green, S., Politis, M., Rallis, K. S., Cortabarría, A. S. D. V., Efthymiou, A., Mureanu, N., Dalrymple, K. V., Scottà, C., Lombardi, G., Tribe, R. M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.737862 · Cited by 48
Self-citation
Competing‐risks model in screening for pre‐eclampsia in twin pregnancy by maternal characteristics and medical history
Francisco, C., Wright, D., Benkő, Z., Syngelaki, A., & Nicolaides, K. H. (2017) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.17529 · Cited by 47
Self-citation
Canadian stroke best practice consensus statement: Secondary stroke prevention during pregnancy
Swartz, R. H., Ladhani, N. N. N., Foley, N. C., Nerenberg, K. A., Bal, S. S., Barrett, J. F. R., Bushnell, C., Chan, W., Chari, R. S., Dowlatshahi, D. D., et al. (2017) · International Journal of Stroke · doi:10.1177/1747493017743801 · Cited by 47
Diet and exercise for preeclampsia prevention in overweight and obese pregnant women: systematic review and meta-analysis
Syngelaki, A., Campos, M. S., Roberge, S., Andrade, W. S., & Nicolaides, K. H. (2018) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2018.1481037 · Cited by 49
Self-citation

Authors: Rolnik, D. L., Wright, D., Poon, L. C., O’Gorman, N., Syngelaki, A., de Paco Matallana, C., Akolekar, R., Cicero, S., Janga, D., Singh, M., Molina, F. S., Persico, N., Jani, J. C., Plasencia, W., Papaioannou, G., Tenenbaum-Gavish, K., Meiri, H., Gizurarson, S., Maclagan, K., & Nicolaides, K. H.
Affiliations: Université Libre de Bruxelles (BE)
King's College Hospital (GB)
ORCID: Rolnik, Daniel L.
Wright, David
Poon, Liona C.
O’Gorman, Neil
Syngelaki, Argyro
Akolekar, Ranjit
Singh, Mandeep
Molina, Francisca S.
Persico, Nicola
Jani, Jacques C.
Plasencia, Walter
Papaioannou, George
Meiri, Hamutal
Maclagan, Kate
Nicolaides, Kypros H.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2017-08-17
Volume: 377
Issue: 7
Pages: 613-622
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1704559
OpenAlex: W2730504020
Cited by: 2,287
References: 24
Citations by year: 2026: 252 · 2025: 277 · 2024: 231 · 2023: 274 · 2022: 257 · 2021: 249 · 2020: 265 · 2019: 212 · 2018: 196 · 2017: 69
FWCI: 238.94
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Research Portal (King's College London) (publishedVersion, other-oa)
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
RISalud Institutional Health Repository of Andalucía (submittedVersion, other-oa)
Funders: Imperial College London
Imperial College Healthcare NHS Trust
University College London
European Commission (FP7-HEALTH-2013INNOVATION, 601852, HEALTH-2013)
Fetal Medicine Foundation
FP7 Health (601852)
Topics: Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
Health Sciences › Medicine › Clinical Neurology › Neurological Complications and Syndromes
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and fetal brain pathology
Keywords: low-dose aspirin, preterm preeclampsia, high-risk pregnancy, preeclampsia prevention, singleton pregnancy, drug safety in pregnancy, adverse neonatal outcomes
MeSH terms: Adult, Aspirin, Double-Blind Method, Female, Humans, Infant, Newborn, Pre-Eclampsia, Pregnancy, Pregnancy Complications, Pregnancy Outcome, Risk, Incidence, Kaplan-Meier Estimate, Intention to Treat Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks